More people in the UK are at risk of a hereditary form of cardiac amyloidosis, a potentially fatal heart condition, than previously thought, according to a new study led by researchers at UCL (University College London) and Queen Mary University of London.
Evonik lays off 2,000 staffers; EurekaBio gets $40M for viral vector production; Sarepta unfazed by Novo-Catalent deal
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more. Evonik has cut 2,000 staff members